Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

Summary The DAPT score is a recently-proposed decision tool for guiding optimal duration of dual antiplatelet therapy (DAPT). It showed modest accuracy in prior derivation and validation cohorts of patients with ≥12 months DAPT. This study was aimed to evaluate the validity of the DAPT score in a co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis and haemostasis 2017, Vol.117 (10), p.1989-1999
Hauptverfasser: Harada, Yukinori, Michel, Jonathan, Lohaus, Raphaela, Mayer, Katharina, Emmer, Roberto, Lena Lahmann, Anna, Colleran, Roisin, Giacoppo, Daniele, Wolk, Annabelle, Berg, Jurrien M. ten, Neumann, Franz-Josef, Han, Yaling, Adriaenssens, Tom, Tölg, Ralph, Seyfarth, Melchior, Maeng, Michael, Zrenner, Bernhard, Jacobshagen, Claudius, Wöhrle, Jochen, Kufner, Sebastian, Morath, Tanja, Ibrahim, Tareq, Bernlochner, Isabell, Fischer, Marcus, Schunkert, Heribert, Laugwitz, Karl-Ludwig, Mehilli, Julinda, A. Byrne, Robert, Kastrati, Adnan, Schulz-Schüpke, Stefanie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary The DAPT score is a recently-proposed decision tool for guiding optimal duration of dual antiplatelet therapy (DAPT). It showed modest accuracy in prior derivation and validation cohorts of patients with ≥12 months DAPT. This study was aimed to evaluate the validity of the DAPT score in a cohort of patients with 6 or 12 months DAPT after implantation of predominantly second-generation drug-eluting stents. We analyzed data of patients enrolled in the ISAR-SAFE trial. Patients were classified into low (
ISSN:0340-6245
2567-689X
DOI:10.1160/TH17-02-0101